Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Analyze the trade-offs between Sp 500 ETFs and index funds in retirement strategies, focusing on costs, taxes, and simplicity.
25,310 articlesHims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
MicroStrategy stock rose about 5% as Bitcoin momentum boosted interest in its sizable BTC treasury, underscoring the ...
Celo Foundation is awarding Opera a one-time grant of 160 million CELO tokens to strengthen its long-term Web3 strate...
Both ServiceNow and Salesforce fell roughly 5% on the latest trading session as AI licensing concerns rattled investo...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
Meta plans to cut about 8,000 jobs as part of a broader AI infrastructure push. The move shifts investor attention to...
April's CPI rose 3.8% year over year, signaling ongoing cost pressure for households. This report captures how famili...
A sharp move in bicara stock 50% has spotlighted a bold biotech bet that now accounts for nearly a third of one inves...
Graduates entering May 2026 face a louder AI-driven job scare than cheers. This report examines how the sound graduat...
Mel Robbins, the millionaire podcaster, pushes back against the Gen Z lazy stereotype, arguing that today’s young wor...
MicroStrategy is pursuing a sizable buyback of zero-coupon convertible notes, a move some critics say reveals liquidi...